2015
DOI: 10.1182/asheducation-2015.1.471
|View full text |Cite
|
Sign up to set email alerts
|

When and why should patients with hematologic malignancies see a palliative care specialist?

Abstract: Palliative care is a multidisciplinary approach to symptom management, psychosocial support, and assistance in treatment decision-making for patients with serious illness and their families. It emphasizes well-being at any point along the disease trajectory, regardless of prognosis. The term "palliative care" is often incorrectly used as a synonym for end-of-life care, or "hospice care". However, palliative care does not require a terminal diagnosis or proximity to death, a misconception that we will address i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
96
0
3

Year Published

2016
2016
2022
2022

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 118 publications
(100 citation statements)
references
References 41 publications
1
96
0
3
Order By: Relevance
“…2226 However, these findings have not affected the care of patients with hematologic malignancies, in part because of the lack of evidence supporting the benefits of palliative care in this population. 27 In the present study, only 2 patients randomized to receive standard transplant care received a palliative care consultation, illustrating the infrequent use of palliative care in this population. This study also suggests that the benefits of palliative care may extend beyond patients with solid tumors.…”
Section: Discussionmentioning
confidence: 67%
“…2226 However, these findings have not affected the care of patients with hematologic malignancies, in part because of the lack of evidence supporting the benefits of palliative care in this population. 27 In the present study, only 2 patients randomized to receive standard transplant care received a palliative care consultation, illustrating the infrequent use of palliative care in this population. This study also suggests that the benefits of palliative care may extend beyond patients with solid tumors.…”
Section: Discussionmentioning
confidence: 67%
“…Severity was categorized as high (rated 8-10 out of 10), moderate (5-7), low (1-4), or no severity (0). Symptoms are derived from the Edmonton Symptom Assessment Scale (ESAS).…”
Section: Figurementioning
confidence: 99%
“…acute myeloid leukemias, diffuse large B-cell non-Hodgkin lymphomas). Although the latter treatments may lead to cure—unlike what is typically possible with advanced solid tumors—treatment can cause significant morbidity and distress placed on patients and their caregivers(1-5), and it is not a guarantee. Despite experiencing such high levels of distress, patients with hematologic cancers tend to have less access to palliative care services and greater use of low-value, aggressive care near the end of life(6-11).…”
Section: Introductionmentioning
confidence: 99%
“…LeBlanc and El-Jawahri suggested some potential ‘flags' for integration of SPC in HM patients including patients with high symptom burden or refractory symptoms, with prolonged hospitalization for allogeneic stem cell transplantation, with significant psychological distress, with difficulties in coping with their illness, with complex family and social needs, with significant and/or persistent misperceptions about their illness trajectory and overall prognosis, and patients with poor prognosis and limited life expectancy [35]. …”
Section: Potential Indications For Palliative Care Needmentioning
confidence: 99%
“…LeBlanc and El-Jawahri suggested the use of the so called ‘surprise question' (Would you be surprised if this patient died in the next 12 months?) [35,36]. However, respecting the very different trajectory of aggressive and chronical HMs, this question seems not to be an appropriate instrument to identify HM patients with SPC needs in general.…”
Section: Potential Indications For Palliative Care Needmentioning
confidence: 99%